Skip to main content
. 2003 Oct 28;89(9):1743–1749. doi: 10.1038/sj.bjc.6601334

Figure 2.

Figure 2

Survivin expression in ependymomas using the sc-10811 antisera: (A) myxopapillary ependymoma, (B) grade II ependymoma, (C) grade II ependymoma, and (D) anaplastic ependymoma.